Fractional Radiofrequency Microneedling is a Safe Monotherapy for Acne Scarring
A recent systemic review found FRM to be an effective treatment modality on its own for managing facial acne scars.
Related Articles
Tralokinumab and Acitretin in Lamellar Ichthyosis
This case report describes a man in his 30s who presented with severe and generalized congenital ichthyosis and was treated with a combination of tralokinumab…
Top 5 Articles of the Week: January 5-10
Explore the top headlines of the week including clinical trial updates, FDA announcements, and expert insights.
The Weekly Roundup: January 5 – 11
In case you missed it, this week we had news about phase 2b enrollment for VYNE’s vitiligo gel, the impact of anti-inflammatory moisturizers for AD,…
ICYMI: Eirion ET-02’s Successful Phase 1 Trial Results for Androgenic Alopecia Treatment
The 5% dosage showed a 6-fold increase in non-vellus hair count after just 5 weeks.
State-of-the-State Update: Chronic Hand Eczema
Chronic hand eczema poses diagnostic and treatment challenges due to its multifaceted etiology. New therapies like JAK inhibitors offer hope.
Low-Dose Naltrexone Use in Biopsy-Proven Lichen Planus of the Nails
This case series examines the effectiveness of low-dose naltrexone in treating nail lichen planus.
DFD-29: The Journey to FDA Approval and a New Era in Rosacea Management
DFD-29, FDA-approved in 2024, revolutionizes rosacea management by addressing both erythema and inflammatory lesions with a novel extended-release formulation.